Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Royal Philips
Health care delivery has been transformed over the past decade, and so has Royal Philips, whose CEO Frans van Houten explains why both were necessary, and the extra impetus for system-wide change following the COVID-19 pandemic.
The $1.5tn proposal includes limited information about the US FDA, but makes pandemic recovery a clear priority.
Missteps and misconceptions are rife among medtech start-ups when it comes to their next strategic move en route to market or to exit.
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.